LAXAI is a fully integrated contract research and development organization that delivers solutions in drug discovery, early formulation development, chemical process development, and GMP manufacturing for innovator pharmaceutical, biotech, and animal health companies globally. Over the years, our focus has been on providing highly efficient scientific solutions, which has enabled us to partner on more than 20 integrated drug discovery programs and multiple medicinal chemistry focussed FTE collaborations. As a result, we have delivered clinical candidates and technology platforms in Oncology, Rheumatoid Arthritis, and Antibacterial respectively. Further, owing to our strength in chemistry and our experience in solving complex problems, we have been engaged on a number of chemical process development and GMP manufacturing projects by innovator pharmaceutical companies. This experience, spanning more than a decade, has enabled us to develop deep expertise in custom NCEs, and custom manufactured advanced intermediates and fine chemicals.
Wednesday, 18th November, 2020
10:00am GMT (UTC+0)
hosted by Lilly Xu, Ph.D. Senior Vice President, DMPK & Exploratory Toxicology Dept, ChemPartner